Toshiba Medical Introduces Aquilion Prime SP CT System at RSNA 2017
Technology | Computed Tomography (CT) | December 13, 2017

December 13, 2017 — Toshiba Medical, a Canon Group company, introduced its new Aquilion Prime SP...

Cordis and Medinol Announce FDA Approval of EluNIR Drug-Eluting Stent System
Technology | Stents Drug Eluting | December 13, 2017

December 13, 2017 — Cordis, a Cardinal Health company, and Medinol recently announced U.S. Food and Drug...

Videos | Magnetic Resonance Imaging (MRI) | December 13, 2017

Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of...

The Corus CAD genetic test is a simple, noninvasive blood test that is clinically available for the assessment of obstructive coronary artery disease.

The Corus CAD gene expression test is a simple, noninvasive blood test that is available to assess a patient’s current likelihood of having obstructive coronary artery disease (CAD).

 

Feature | Genetic Testing | December 13, 2017 | Andrew Waxler, M.D., FACC

The diagnosis and management of cardiovascular disease has long followed a familiar approach. Patients see their...

AI Visualize Inc. Debuts Artificial Intelligence Cloud Image Visualization Platform at RSNA 2017
Technology | Remote Viewing Systems | December 13, 2017

December 13, 2017 — AI Visualize Inc. debuted its new cloud-based...

GE Healthcare Launches Blanket-Like Air Technology MRI Coils
Technology | Magnetic Resonance Imaging (MRI) | December 13, 2017

December 13, 2017 — GE Healthcare announced U.S. FDA 510(k) clearance of its new Air Technology, what it calls an...

New Oral Anticoagulant Drugs Associated with Lower Kidney Risks
News | Antiplatelet and Anticoagulation Therapies | December 12, 2017

December 12, 2017 — Mayo Clinic researchers have shown a link between which type of...

VitalConnect Secures Fifth FDA Clearance for Patient Monitoring Device
Technology | Wearable Sensors | December 12, 2017

December 12, 2017 — VitalConnect Inc. announced its fifth 510(k) market clearance from the U.S. Food and Drug...

Toshiba Vantage Galan 3T XGO Edition MRI Features New Advanced Gradient
Technology | Magnetic Resonance Imaging (MRI) | December 11, 2017

December 11, 2017 — Toshiba Medical, a Canon Group company, demonstrated the Vantage Galan 3T XGO Edition...

CorInnova Awarded 2017 InnoSTARS Prize for EpicHeart Soft Robotic Heart Assist Device
News | Artificial Heart | December 11, 2017

December 11, 2017 — CorInnova Inc. recently announced it was awarded second prize in the “2017 InnoSTARS” life...

Philips Debuts IQon Elite Spectral CT Scanner at RSNA 2017
Technology | Computed Tomography (CT) | December 11, 2017

December 11, 2017 — At the 2017 Radiological Society of North America (RSNA) Annual Meeting, Philips unveiled the...

New Siemens Healthineers Dashboard Application Provides Insights into Cardiology Operations
Technology | Analytics Software | December 11, 2017

December 11, 2017 — Siemens Healthineers has launched teamplay Cardio, a new cardiology...

Stereotaxis Receives Regulatory Approval of e-Contact Module in Canada
Technology | Ablation Systems | December 08, 2017

December 7, 2017 — Stereotaxis Inc. announced it has received regulatory clearance from Health Canada for its e-...

ECG Study of NBA Players Shows Need for Sport-Specific Normative Data and Guidelines
News | ECG | December 08, 2017

December 8, 2017 — Cardiologists at NewYork-Presbyterian/Columbia University Irving Medical Center compared...

New Study Suggests Protein Could Protect Against Coronary Artery Disease

Patients with no obstructed blood flow in the coronary arteries had higher levels of CXCL5 (blue) compared to patients with moderate levels (green) or lower levels (yellow) of CXCL5, who had increased severity of coronary obstructions (indicated by the arrows). Credit: Schisler lab

News | Cardiac Diagnostics | December 07, 2017

December 7, 2017 — The buildup of plaque in the heart’s arteries is an unfortunate part of aging. But by studying...

Overlay Init